Zahid Zahidov

Zahid Zahidov

Auto-generated profile, based on publicly available information

Zahid Zahidov


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2026 in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
Verified
Journal Article
Open access
ZZZahid Zahidov
Zahid Zahidov
TMTapdıq Memmedov
Tapdıq Memmedov
ZZZülfi Zahidli
Zülfi Zahidli
Background/Aim: Hepatic cavernous hemangioma (HCH) is the most common benign liver tumor, but the management of small lesions remains controversial. This prospective study evaluated the efficacy, safety, and short- and long-term clinical outcomes of ultrasound (US)-guided percutaneous microwave (MW) ablation in patients with HCH under 5 cm exhibiting significant growth during follow-up.Materials and Methods: Between March 2010 and February 2015, 38 patients with HCH were prospectively enrolled at the Department of General Surgery, I.M. Sechenov First Moscow State Medical University (Moscow, Russia); those with lesions larger than 5 cm were excluded. Diagnosis was confirmed by contrast-enhanced multislice computed tomography (CT), and patients were followed with serial US and CT. Thirteen patients (34.2%) who showed a 2–2.5-fold increase in lesion size within 1.5–3 years underwent US-guided percutaneous MW ablation under intravenous anesthesia (14G probe; 100–120°C; 10–20 minutes). Patients were followed with clinical examination, liver function tests, and imaging.Results: The 13 treated patients (mean age 44 years; 9 women, 4 men) had 12 solitary and 1 multiple (four lesions) hemangiomas, predominantly right-lobed. Three patients (23.1%) were asymptomatic and ten (76.9%) had right upper-quadrant pain. A single session sufficed in 11 patients (84.6%); 2 (15.4%) required a second session for recurrence. Transient 2–3-fold ALT/AST elevations normalized by day 5. Six patients developed transient fluid collections that resolved spontaneously within 6 months; no major complications or procedure-related mortality occurred. Over a mean follow-up of 20 months (range 8–32), the ablation zone was replaced by fibrotic tissue in all patients.Conclusion: US-guided percutaneous MW ablation is an effective, safe, and organ-preserving minimally invasive option for small hepatic cavernous hemangiomas with documented growth, offering a feasible alternative between observation and surgical resection.Keywords: Hemangioma, Liver Neoplasms, Microwave Ablation, Ultrasonography